Sign in

CIK 0001679628

  • Emerging growth company

JUPITER NEUROSCIENCES, INC.

Sign in to watch
Ticker
JUNS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474828381
Phone
+1 561-406-6154
Business address
1001 NORTH US HWY 1, SUITE 504, JUPITER, FL, 33477
Former names
Jupiter Orphan Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-31 Cutler Andrew Jon Director Grant or award · Stock Option (right to buy) +472,222 472,222
2026-06-29 Philipson Tomas Jan Director Grant or award · Stock Option (right to buy) +536,428 536,428
2026-06-02 Brady Allison W Director Grant or award · Stock Option +100,000 100,000
2026-06-02 Elmasri Saleem Chief Financial Officer Grant or award · Stock Option +525,565 525,565
2026-06-02 ROSEN CHRISTER CEO and Chairman Grant or award · Stock Option +747,783 747,783
2026-06-02 Hemmerly Nicholas H. Director Grant or award · Stock Option +100,000 100,000
2026-06-02 Kampf Julie B. Director Grant or award · Stock Option +100,000 100,000
2026-06-02 Silva Alison D. President and COO Grant or award · Stock Option +1,027,304 1,027,304
2026-06-02 Hayward Marshall A. Chief Scientific Officer Grant or award · Stock Option +259,231 259,231
2026-06-02 Weis Holger Director Grant or award · Stock Option +100,000 100,000
2026-06-02 Rosen Alexander Gustaf Erik Chief Administrative Officer Grant or award · Stock Option +341,843 341,843
2026-03-02 Hayward Marshall A. Chief Scientific Officer Option exercise +225,000 2,995,077
2026-03-02 Hayward Marshall A. Chief Scientific Officer Option exercise · Stock Option (right to buy) −225,000 0
2025-07-02 Elmasri Saleem CFO and Secretary Grant or award · Stock Option (right to buy) +102,128 102,128
2025-07-02 Silva Alison D. Pres + Chief Business Officer Grant or award · Stock Option (right to buy) +255,320 255,320
2025-07-01 Silva Alison D. Pres + Chief Business Officer Purchase +250 $1.03 $257 112,277
2025-07-01 Silva Alison D. Pres + Chief Business Officer Purchase +250 $1.03 $257 112,527
2025-07-01 Silva Alison D. Pres + Chief Business Officer Purchase +250 $1.03 $259 112,777
2025-07-01 ROSEN CHRISTER CEO and Chairman Purchase +500 $1.01 $505 11,075,792
2025-07-01 ROSEN CHRISTER CEO and Chairman Purchase +3,100 $1.02 $3K 11,078,892

Page 1 of 3 · 58 trades